David Baxley Spetzler

CIK: 0002071953

Transaction Breakdown

Open Market Buys (P)1 (7.1%)

High conviction signal

Open Market Sales (S)3 (21.4%)

Position reduction

Option Exercises (M)3 (21.4%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)4 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAI

Caris Life Sciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

CAI
Caris Life Sciences, Inc.
Sep 4, 2026
Sale(S)
Direct
119.2K shares at avg. $24.76$3.0M
CAI
Caris Life Sciences, Inc.
Sep 4, 2026
Exercise(M)
Direct
250K shares at avg. $2.44$610K
CAI
Caris Life Sciences, Inc.
Sep 3, 2026
Exercise(M)
Direct
1M shares at avg. $2.44$2.4M
CAI
Caris Life Sciences, Inc.
Sep 3, 2026
Sale(S)
Direct
84.9K shares at avg. $25.32$2.1M
CAI
Caris Life Sciences, Inc.
Sep 3, 2026
Sale(S)
Direct
393.1K shares at avg. $24.76$9.7M
CAI
Caris Life Sciences, Inc.
May 15, 2026
Tax Payment(F)
Direct
13.9K shares at avg. $15.25$211K
CAI
Caris Life Sciences, Inc.
Mar 6, 2026
Award(A)
Direct
83.2K shares-
CAI
Caris Life Sciences, Inc.
Nov 7, 2025
Purchase(P)
Direct
400 shares at avg. $23.85$10K
CAI
Caris Life Sciences, Inc.
Aug 11, 2025
Tax Payment(F)
Direct
63.5K shares at avg. $29.75$1.9M
CAI
Caris Life Sciences, Inc.
Jun 20, 2025
Exercise(M)
Direct
75K shares at avg. $2.44$183K
CAI
Caris Life Sciences, Inc.
Jun 20, 2025
Tax Payment(F)
Direct
34.8K shares at avg. $27.25$948K
CAI
Caris Life Sciences, Inc.
Jun 18, 2025
Award(A)
Direct
132.4K shares-
CAI
Caris Life Sciences, Inc.
Mar 3, 2025
Award(A)
Stock Option
Direct
750K shares-
CAI
Caris Life Sciences, Inc.
Mar 3, 2025
Disposition(D)
Direct
700.5K shares at avg. $18.60$13.0M

		Type	Shares	Price		Ownership
Sep 4, 2026	CAI Caris Life Sciences, Inc.	Sale(S)	119,212	$24.76	$2,951,117	Direct
Sep 4, 2026	CAI Caris Life Sciences, Inc.	Exercise(M)	250,000	$2.44	$610,000	Direct
Sep 3, 2026	CAI Caris Life Sciences, Inc.	Exercise(M)	1,000,000	$2.44	$2,440,000	Direct
Sep 3, 2026	CAI Caris Life Sciences, Inc.	Sale(S)	84,900	$25.32	$2,149,676	Direct
Sep 3, 2026	CAI Caris Life Sciences, Inc.	Sale(S)	393,100	$24.76	$9,733,313	Direct
May 15, 2026	CAI Caris Life Sciences, Inc.	Tax Payment(F)	13,856	$15.25	$211,304	Direct
Mar 6, 2026	CAI Caris Life Sciences, Inc.	Award(A)	83,162	-	$0	Direct
Nov 7, 2025	CAI Caris Life Sciences, Inc.	Purchase(P)	400	$23.85	$9,540	Direct
Aug 11, 2025	CAI Caris Life Sciences, Inc.	Tax Payment(F)	63,509	$29.75	$1,889,393	Direct
Jun 20, 2025	CAI Caris Life Sciences, Inc.	Exercise(M)	75,000	$2.44	$183,000	Direct
Jun 20, 2025	CAI Caris Life Sciences, Inc.	Tax Payment(F)	34,782	$27.25	$947,810	Direct
Jun 18, 2025	CAI Caris Life Sciences, Inc.	Award(A)	132,428	-	-	Direct
Mar 3, 2025	CAI Caris Life Sciences, Inc.	Award(A) Stock Option	750,000	-	-	Direct
Mar 3, 2025	CAI Caris Life Sciences, Inc.	Disposition(D)	700,509	$18.60	$13,029,467	Direct

1-14 of 14 transactions

About Spetzler David Baxley

Spetzler David Baxley (SEC CIK 0002071953) files insider reports with the SEC as President of Caris Life Sciences, Inc. (CAI).

Signal8 holds 7 ownership filings by Spetzler David Baxley (1 Form 3, 6 Form 4), filed between Jun 17, 2025 and Sep 4, 2026. Those filings report 14 transactions, from Mar 3, 2025 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Spetzler David Baxley's filings is in IRVING, TX.

Recent filings by Spetzler David Baxley

Sep 4, 2026: Open-market sale of CAI shares (Form 4, code S).
Sep 4, 2026: Option exercise of CAI shares (Form 4, code M).
Sep 3, 2026: Option exercise of CAI shares (Form 4, code M).
Sep 3, 2026: Open-market sales of CAI shares (2 lines, Form 4, code S).
May 15, 2026: Tax withholding of CAI shares (Form 4, code F).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes